Effectiveness and safety of LMWH treatment in patients with cancer diagnosed with nonhigh-risk venous thromboembolism (VTE): Results of the Turkish observational study (TREBECA).

Ozaslan, ErsinOzkan, MetinCicin, IrfanBenekli, MustafaKocer, MuratUysal, MukreminOksuzoglu, Berna2024-06-122024-06-1220170732-183X1527-7755https://doi.org/10.1200/JCO.2017.35.15_suppl.e21656https://hdl.handle.net/20.500.14551/2593353rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- JUN 02-07, 2017 -- Chicago, IL[Abstract Not Available]en10.1200/JCO.2017.35.15_suppl.e21656info:eu-repo/semantics/closedAccess[No Keywords]Effectiveness and safety of LMWH treatment in patients with cancer diagnosed with nonhigh-risk venous thromboembolism (VTE): Results of the Turkish observational study (TREBECA).Conference Object35Q1WOS:000411932205189